MIGUEL ÁNGEL
POZO GARCÍA
Catedrático de universidad
Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas
Madrid, EspañaPublications in collaboration with researchers from Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (9)
2017
-
Effects of a sativex-like combination of phytocannabinoids on disease progression in R6/2 mice, an experimental model of huntington’s disease
International Journal of Molecular Sciences, Vol. 18, Núm. 4
-
Insulin regulates astrocytic glucose handling through cooperation with IGF-I
Diabetes, Vol. 66, Núm. 1, pp. 64-74
2016
-
Dysregulation of the endocannabinoid signaling system in the cerebellum and brainstem in a transgenic mouse model of spinocerebellar ataxia type-3
Neuroscience, Vol. 339, pp. 191-209
-
The insulin-like growth factor I receptor regulates glucose transport by astrocytes
GLIA, Vol. 64, Núm. 11, pp. 1962-1971
2014
-
A longitudinal FDG-PET study of transgenic mice overexpressing GSK- 3β in the brain
Current Alzheimer Research, Vol. 11, Núm. 2, pp. 175-181
-
Longitudinal assessment of a transgenic animal model of tauopathy by FDG-PET imaging
Journal of Alzheimer's Disease, Vol. 40, Núm. S1
2013
-
Neuroprotective properties of standardized extracts of hypericum perforatum on rotenone model of parkinson's disease
CNS and Neurological Disorders - Drug Targets, Vol. 12, Núm. 5, pp. 665-679
2012
-
Prolonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 mice
Journal of Neuroinflammation, Vol. 9
2011
-
Statistical parametric maps of 18F-FDG PET and 3-D autoradiography in the rat brain: A cross-validation study
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 38, Núm. 12, pp. 2228-2237